Mutual of America Capital Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-16,287
| Closed | -$1.6M | – | 1355 |
|
|
2025
Q2 | $1.6M | Sell |
16,287
-568
| -3% | -$53.7K | 0.02% | 880 |
|
|
2025
Q1 | $1.56M | Sell |
16,855
-445
| -3% | -$41K | 0.02% | 907 |
|
|
2024
Q4 | $1.57M | Sell |
17,300
-337
| -2% | -$30.9K | 0.02% | 918 |
|
|
2024
Q3 | $1.7M | Sell |
17,637
-1,049
| -6% | -$102K | 0.02% | 933 |
|
|
2024
Q2 | $1.72M | Sell |
18,686
-759
| -4% | -$70.4K | 0.02% | 915 |
|
|
2024
Q1 | $1.79M | Sell |
19,445
-721
| -4% | -$67.6K | 0.02% | 937 |
|
|
2023
Q4 | $1.92M | Sell |
20,166
-1,051
| -5% | -$98.2K | 0.02% | 916 |
|
|
2023
Q3 | $1.98M | Sell |
21,217
-2,455
| -10% | -$227K | 0.02% | 873 |
|
|
2023
Q2 | $2.16M | Sell |
23,672
-2,471
| -9% | -$203K | 0.02% | 875 |
|
|
2023
Q1 | $1.92M | Sell |
26,143
-547
| -2% | -$47.3K | 0.02% | 912 |
|
|
2022
Q4 | $2.23M | Buy |
26,690
+624
| +2% | +$56.3K | 0.03% | 858 |
|
|
2022
Q3 | $2.52M | Sell |
26,066
-1,166
| -4% | -$139K | 0.03% | 740 |
|
|
2022
Q2 | $2.86M | Sell |
27,232
-2,497
| -8% | -$319K | 0.04% | 718 |
|
|
2022
Q1 | $5.12M | Buy |
29,729
+570
| +2% | +$85.2K | 0.05% | 523 |
|
|
2021
Q4 | $4.72M | Buy |
29,159
+385
| +1% | +$61.9K | 0.05% | 595 |
|
|
2021
Q3 | $4.29M | Buy |
28,774
+431
| +2% | +$89.6K | 0.04% | 611 |
|
|
2021
Q2 | $6.94M | Sell |
28,343
-1,391
| -5% | -$365K | 0.07% | 359 |
|
|
2021
Q1 | $7.87M | Sell |
29,734
-560
| -2% | -$158K | 0.08% | 292 |
|
|
2020
Q4 | $8.89M | Sell |
30,294
-88
| -0.3% | -$22.6K | 0.1% | 214 |
|
|
2020
Q3 | $7.18M | Buy |
30,382
+24
| +0.1% | +$5.46K | 0.1% | 226 |
|
|
2020
Q2 | $6.03M | Buy |
30,358
+360
| +1% | +$67.1K | 0.09% | 265 |
|
|
2020
Q1 | $5.51M | Buy |
29,998
+985
| +3% | +$175K | 0.09% | 250 |
|
|
2019
Q4 | $4.84M | Buy |
29,013
+252
| +0.9% | +$37.5K | 0.06% | 448 |
|
|
2019
Q3 | $3.77M | Buy |
28,761
+3,033
| +12% | +$395K | 0.05% | 547 |
|
|
2019
Q2 | $3.12M | Buy |
25,728
+66
| +0.3% | +$7.83K | 0.04% | 661 |
|
|
2019
Q1 | $3.16M | Buy |
25,662
+24,936
| +3,435% | +$3.13M | 0.05% | 637 |
|
|
2018
Q4 | $85K | Buy |
726
+176
| +32% | +$20.7K | ﹤0.01% | 1166 |
|
|
2018
Q3 | $69K | Buy |
550
+445
| +424% | +$49.1K | ﹤0.01% | 1200 |
|
|
2018
Q2 | $9K | Buy |
+105
| New | +$7.71K | ﹤0.01% | 1253 |
|
Other funds holding AMED
IA
MCI
HNB
Mutual of America Capital Management's AMED Position: Q3 2025 in Review
Mutual of America Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 16,287 shares — an estimated $1.6M sold.
Mutual of America Capital Management first reported a position in AMED in Q2 2018 and held it in 29 quarters. The position peaked at $8.89M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Mutual of America Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Mutual of America Capital Management sold 16,287 Amedisys shares in Q3 2025, an estimated $1.6M.
- Mutual of America Capital Management first reported a position in Amedisys in Q2 2018 and held it in 29 quarters.
- Mutual of America Capital Management's Amedisys position peaked at $8.89M in Q4 2020.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Mutual of America Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.